Thus, Nrf2 has a complex role in TME, and its activation can occur in tumor-associated macrophages (TAMs) and facilitate an anti-inflammatory, immunosuppressive tumor immune microenvironment (TIME) [108]. Here, NFE2L2 is linked to neoplasm.